Pulmonary Histoplasmosis: A Clinical Update

Area of Science:

• Mycology and Infectious Diseases
• Pulmonology

Background:

• Histoplasma capsulatum is a dimorphic fungus causing histoplasmosis.
• Endemic areas include North, Central, and South America, particularly the Mississippi and Ohio River Valleys.
• Pulmonary histoplasmosis presents with varied symptoms, mimicking other respiratory conditions.

Purpose of the Study:

• To review the epidemiology, pathology, diagnosis, clinical presentations, and management of pulmonary histoplasmosis.
• To emphasize the importance of understanding these aspects for successful diagnosis and treatment.

Main Methods:

• Review of current literature on Histoplasma capsulatum and histoplasmosis.
• Discussion of diagnostic testing performance and therapeutic options.

Main Results:

• Pulmonary histoplasmosis can present diversely, requiring careful differentiation from other diseases.
• Treatment decisions depend on disease severity and patient immune status.
• Liposomal amphotericin B and itraconazole are key antifungal agents.

Conclusions:

• Effective management of histoplasmosis hinges on accurate diagnosis and timely, appropriate therapy.
• All immunocompromised patients and those with severe or chronic pulmonary disease require treatment.
• Understanding the multifaceted nature of histoplasmosis is essential for clinicians.